pharma

YOU MIGHT BE INTERESTED IN

Anti-Counterfeiting Americas
Increasing efforts are being made to protect the national supply chain for medicines distribution. In the US, the pharmaceutical supply chain involves the daily delivery of approximately 13 million prescription products to pharmacies, hospitals, clinics and other healthcare provider locations (Source: Urch Publishing, July 2009). Visiongain's Anti-Counterfeiting Americas conference will provide valuable insights, into the latest issues and track and trace packaging technologies shaping the fields of security and supply chain management, with leading experts presenting the best-practices on tackling pharmaceutical counterfeiting and fraud, improving the integrity of distribution channels and relationships between key parties.
...more details
The World OTC Pharmaceutical Market Analysis & Forecasts, 2008-2023
Visiongain have the pleasure of announcing the latest edition of their industry leading report - The World OTC Pharmaceutical Market, 2008-2023. This edition updates the world OTC market at present and predicts its sales revenues and trends from 2008-2023, including drivers and restraints on the market.
...more details
The Pharmaceutical Wholesale and Distribution Industry Outlook & Analysis 2008
The major problem facing the Wholesale & Distribution industry is its low profit margin which is in the region of only 1-2%. However, this market is entering into a crucial period with many key products losing patent protection, facing heavy generic competition.
...more details
World Generics Market, 2008-2013
The generics market remains a major growth area in the global healthcare market. That growth has been partly driven by cost-containment in several national healthcare sectors, with governments seeking to promote the use of generic products over higher-priced originator products. The global generic pharmaceuticals market was worth over $100bn in 2007, with market growth noticeably higher that that of the overall pharmaceutical market.
...more details

CONFERENCE

...see all

4th Annual Pharmaceutical Anti-Counterfeiting Strategies

Maintaining patient safety and securing the supply chain

7th - 8th September 2009, Hilton London Olympia, London, UK

Download brochure Products

Background Info
Day 1
Day 2
Partners
Past Papers

Silver Sponsor

Associate Sponsors

Marketing Sponsor

Junior Sponsor

Junior Marketing Sponsor

Media Partners

Background Info

Key Speakers
• Andrew Bonser, Director, European Government Affairs, Pfizer World-Wide Pharmaceuticals
• Dr David Gillen, Head of Medical Teams Primary Care BU Europe Canada Australia and NZ, Pfizer
• Tassilo Korab, Executive Director, European Healthcare Compliance Council
• Dirk Broeckx, Secretary-General, APB - Belgian Pharmacists Association
• Janice Kite, Traceability Director Healthcare, GS1
• John Jenkins, BRIDGE Project Co-ordinator, JJ Associates
• Aidan Madden, General Manager, FivePharma
• Dr David Taylor, Professor of Pharmaceutical and Public Health Policy, The School of Pharmacy, University of London
• Julian Harris, Analyst, International Policy Network
• Monika Derecque-Pois, Director General, GIRP
• Christopher Stothers, Senior Associate, Milbank, Tweed, Hadley and McCloy LLP
• Professor Hamid Ghodse, Professor of Psychiatry and International Drug Policy, University of London, Past President, International Narcotics Control Board
• Dr Jim Thomson, Chair, European Alliance for Access to Safe Medicines (EAASM)

Counterfeiting of medicinal products is a growing problem in the developing world, and is an issue that must be addressed by pharmaceutical manufacturers, public health and regulatory bodies alike. In order to efficiently deal with the changing structure of the pharmaceutical industry, manufacturers, regulators and distributors must work together to implement suitable technologies to maintain patient safety, protect brands and R&D investment and streamline business. There remains a huge market for technology companies who can assist the healthcare industry to meet these challenges. Visiongain’s 4th Annual Pharmaceutical Anti-counterfeiting conference will provide valuable insight, into the latest technologies and issues shaping the fields of security and supply chain management, with leading experts presenting the best-practices on tackling pharmaceutical counterfeiting.

By attending Visiongain’s 4th Annual Pharmaceutical Anti-Counterfeiting Strategies conference delegates will gain a comprehensive outlook on the anti-counterfeiting market, from product development to potential applications and market trends.

By attending this conference you will:
• Assess the economic and health cost of fake medicines and how they enter the supply chain
• Implement the latest technological developments
• Examine anti-counterfeiting initiatives: governmental and NGO based initiatives
• Compare the latest strategies of manufacturers/suppliers of authentication and track and trace packaging technologies
• Analyse the market for RFID technologies in pharma manufacturing
• Be part of a unique networking opportunity

Target Audience:
• Pharmaceutical manufacturing and distributing companies
• Wholesalers
• Pharmaceutical packaging and labelling companies
• Anti-counterfeiting technology and service suppliers
• Pharmaceutical specialist couriers
• Public health and regulatory bodies
• Anti-counterfeiting organisations
• Non-governmental healthcare organisations

Who should attend:
VPs, directors, heads and managers of:
• Supply chain
• Distribution
• Security
• Packaging
• Labelling
• Legal counsel
• Regulatory Affairs
• Quality assurance/ Quality control
• Compliance
• Information systems

Day 1

Day One, Monday 7th September 2009

09:30 Registration and refreshments

10:00 Opening address from the chair

Patric Marshall
Sales and Marketing Director, Europe, Middle East and Africa
World-Check

10:10 Looking at the Pfizer’s experiences in the UK and the Public Awareness campaign that they developed and ran in 2009
• Counterfeit medicines represent a very real, widespread and growing illegal trade that threatens public safety, endangers the health of its victims and at worst, counterfeit medicines have even been shown to kill
• The problem of counterfeit medicines is known to exist in both developed and developing countries, although despite the efforts of the WHO there is no standard definition of a counterfeit medicine, which makes information exchange difficult and limits our ability to understand the true extent of the problem
• The WHO estimates that up to 1% of medicines available in the developed world are likely to be counterfeit. This figure rises to 10% globally, although in some developing countries they estimate one third of medicines are counterfeit.
• The MHRA has been active in the war against illegal, unregulated pharmacies supplying counterfeit medicines and has run five ‘Internet Days of Action’ since 2006, cracking down on websites hosted in the UK or taking orders from within our shores
• Pharmaceutical companies also take the issue very seriously and are doing many things to further protect patients from the dangers of counterfeit medicines.

Dr David Gillen
Head of Medical Teams, Primary Care BU Europe Canada Australia and NZ
Pfizer

10:50 Technological and legal measures – How can we protect patients?
• The EC anti-counterfeit proposal for legal measures to protect the supply chain
• Possibilities and limits of technological means to secure product safety
• GIRP’s proposals to strengthen the supply chain

Monika Derecque-Pois
Director General
GIRP

11:30 Morning refreshments

11:50 The impact on value
• Why protect your IP / brand
• How to value your IP / brand
• Impact on value

David Mitchell
Partner
BDO Stoy Hayward

12:30 Illegal internet pharmacies: A framework for coordinated action and cooperation
• Illegal internet pharmacies: Extent of the problem
• Action against illegal Internet pharmacies - what has been done?
• What remains to be done: The need for additional action

Professor Hamid Ghodse
Professor of Psychiatry and International Drug Policy, University of London
Past President, International Narcotics Control Board

13:10 Networking lunch

14:10 Legally binding identification of pharmaceuticals via colour codes
• Facts and figures of counterfeit drugs
• Risks for the different stakeholders
• Micro colour code as one effective method to protect pharmaceutical products
• Colour codes & traceability code

Angelina Rayak
Sales Manager
3S Simons Security Systems

14:50 Bridge and Pharma Traceability Pilot
• About the BRIDGE Project
• Objectives of the Pharma Traceability Project
• Mass serialisation in the supply chain
• What we did and who was involved
• Conclusions and Recommendations

John Jenkins
BRIDGE Project Co-ordinator
JJ Associates

15:30 Developing global standards to increase patient safety – Traceability in healthcare
• A safe and secure supply chain
• Authentication and traceability
• Activities of regulatory bodies and industry worldwide
• Global standards – how do they help fighting counterfeiting?

Janice Kite
Traceability Director Healthcare
GS1

16:10 Afternoon refreshments

16:30 Identifying and overcoming challenges in implementing a traceability system across Europe
• Working solutions for traceability and more: challenges and implementation lessons learned
• Belgian pharmacists against counterfeit: what have the Medicines Control Lab and Aegate got in common?
• Traceability, anti-counterfeit, stock management and patient information: how to get “four for the price of one”?
• Experiences concerning conceptual choices and technical solutions from an up-and-running system

Dirk Broeckx
Secretary-General
APB - Belgian Pharmacists Association

17:10 Presentation to be announced

17:40 Tackling Europe’s anti-counterfeit weaknesses: a patient’s perspective
• Key conclusions from the Counterfeiting Superhighway and Harper reports
• Strengths and weaknesses in the EC’s anti-counterfeiting proposals
• EAASM’s recommendations to further protect European patients through new regulation

Dr Jim Thomson
Chair
European Alliance for Access to Safe Medicines (EAASM)

18:05 Closing remarks from the chair

18:15 Networking Drinks Reception
Take your discussions further and build new relationships in a relaxed and informal setting

Day 2

Day Two, Tuesday 8th September 2009

09:30 Registration and refreshments

10:00 Opening address from the chair

Philip Payne
Business Development Manager (Pharmaceuticals)
RSSL Pharma

10:10 Stumbling block Data Matrix Barcode quality assessment?
• Is barcode quality assessment a necessity?
• The relevant ISO standards
• Additional relevant industry standards
• The measuring procedure
• Barcode verification equipment

Sergej Toedtli
CEO
Vesdo

10:30 Meeting the objectives of the EU Directive: the R&D manufacturers response to supply chain security and product integrity
• What does the Directive say and how effective will the proposed measures be?
• What should be the main criteria for choosing effective solutions to meet the Commission’s objectives?
• What is the industry position and what solutions does it propose to meet the challenges of supply chain security and product integrity?

Andrew Bonser
Director, European Government Affairs
Pfizer World-Wide Pharmaceuticals

11:10 Morning refreshments

11.30 Natural randomness as a fingerprint for product authentication
• How Laser Surface Authentication (LSA) can read the nanoscopic imperfections on the surface of every product or packaging and generates a unique code in a similar way as human biometrics but for 'things'.
• This 'fingerprint' code can be later validated throughout the supply chain.
• Overview of how LSA is being applied to product packaging
• How LSA is being implemented using both database and self-authentication methods in real customer applications
• How LSA complements other supply chain technologies such as data matrix bar codes

Mark McGlade
Director
Ingenia Technology

11:50 Good distribution practices to combat counterfeit medicinal products
• GDP regulatory legislation and guidance
• Global quality systems development
• The components of a GDP System including bona-fides of customers and suppliers
• Effective management of anti-counterfeiting actions

Aidan Madden
General Manager
FivePharma

12:30 Lightening the supply chain burden: product protection strategies
• Repackaging and counterfeiting
• Does covert mean secret?
• Think like a criminal: evaluate the burden of compliance against the ease with which a determined counterfeiter can defeat a protective method
• Evaluate packaging-based and product-based anti-counterfeiting measures by cost, complexity, and effectiveness

Dr Sharon Flank
CEO
InfraTrac

13:10 Networking lunch

14:10 Protecting IP rights
• Trademarks and identity preservation
• A history of branding and quality assurance
• Causes of counterfeiting
• Anti-counterfeiting technology and choice

Julian Harris
Analyst
International Policy Network

14:50 Parallel trade and counterfeiting
• The relationship between parallel trade and counterfeiting: fact and fiction
• Basic framework for the parallel trade of pharmaceuticals
• Recent and future developments

Christopher Stothers
Senior Associate
Milbank, Tweed, Hadley & McCloy LLP

15:30 Drug Counterfeits – an increasing threat to patients’ safety
• Definition
• The main risk factors
• The stake-holders views
• The technical approach
• The logistic approach
• The regulators’ approach

Tassilo Korab
Executive Director
European Healthcare Compliance Council

16:10 Afternoon refreshments

16:30 Intelligent brand protection and document authenticity
• Secured protection
• Intelligent design system
• Security design for brand protection
• Security design features
• Document authenticity

Dr Boglárka Papp
Marketing and Sales Director
Jura JSP

16:50 Global strategies for improving medicines supply and reducing the threat from counterfeit pharmaceuticals
• Medicines counterfeiting is a world-wide threat to public health that demands sustained and co-ordinated international action for its control.
• In countries such as those of sub-Saharan Africa people are also at high risk from poor quality medicines that may have been accidentally adulterated, produced to a poor standard and/or degraded by inappropriate storage. Such problems should not be ignored. But neither should they be confused with deliberate counterfeiting.
• The WHO’s IMPACT (International Medical Products Anti-Counterfeiting Taskforce) initiative built on earlier work aimed at preventing medicines counterfeiting. Funded mainly by (European) government resources, it successfully encouraged international collaboration to curb counterfeiting through measures like more robust policing, stronger penalties, enhanced surveillance and better medicinal product identification schemes.

Dr David Taylor
Professor of Pharmaceutical and Public Health Policy,
The School of Pharmacy
University of London

17:30 Chair’s closing remarks

17:35 End of conference

Partners

Silver Sponsor:

World-Check
Trusted by more than 3,800 institutions in over 160 countries, including 49 of the world’s top 50 banks, World-Check offers an end-to-end solution for assessing, managing and monitoring financial, regulatory and reputational risks.
World-Check's global database of Politically Exposed Persons and heightened risk individuals and organisations, Enhanced Due Diligence (EDD) reports, passport verification and country risk assessment tools provide the means to address the full spectrum of risk across all markets and industries.
Represented across five continents, World-Check's international research team monitors emerging risks in more than 50 languages, covering over 240 countries and territories worldwide. For further information, please visit www.world-check.com

Associate Sponsor:

3S Simons Security Systems
3S Simons Security Systems is a renowned manufacturer of anti- counterfeiting technologies. On the basis of the micro colour-codes SECUTAG®, 3S has developed individual industry solutions against product piracy. The protection of primary and secondary packaging is one of the most common requirements for the pharmaceutical industry. Folded boxes, tubes, blisters, bottles and closures are protected by SECUTAG®, independent of their material. The versatile product portfolio of 3S also includes security labels, seals, holograms and traceability devices. The colour-code technology is legally binding and saves brand owners from unjustifi ed product liability claims. For further information, please visit www.3SGmbH.com

KryoTrans
As the pharmaceutical market reaches ever wider, and as regulatory demands for temperature-controlled shipments become tougher, so the need for an utterly reliable, simple, passive and reusable container becomes greater: especially one which can deliver at a competitive, cost-effective price.
The KryoTrans range, now in use with pharmaceutical companies all around the world, offers a powerful response to these challenges. With customers routinely enjoying compliance times of 240 hours plus, even in the toughest ambient conditions, KryoTrans is building a formidable reputation for solving formidable and expensive problems.
KryoTrans stands for Quality, in respect of a tough and simple solution that delivers over and over again, and Integrity, with the built-in data logger proving that the goods have arrived in compliance, again.
KryoTrans containers use phase-change configurations for -20, 2 - 8 and +20 requirements, with dry ice alternatives available for lower temperatures. The results of all shipments are recorded on the integral data logger, which not only records internal and external temperatures (as well as occasions upon which the container may have been opened) but also displays the internal temperature (showing highest and lowest encountered during the trip) for easy product acceptance and sign-off.
One configuration, all year round, takes the guesswork out of trip planning and simplifies inventory control; it also ensures that whether the issue is cold starting temperatures or exposure to high ambients at the destination the consignment will still be protected. For further information, please visit www.kryotrans.com

Ingenia Technology
Ingenia Technology is an emerging international company in the authentication and verification of product packaging, papers, plastics and metals, as used in brand protection, documents, ID cards and item level authentication. Ingenia Technology was founded in 2003 with its headquarters in London. The company’s key product is the Laser Surface Authentication (LSA) system – a new, proprietary, and patented technology to rapidly analyze the nanoscopic imperfections in the surface of any item and create a unique digital serial code for the item. This code, which has been described as being like a fingerprint or DNA sequence for the item, is unique for every document, card and carton and can be used to uniquely and unambiguously identify the product. The LSA technology has won a number of prestigious global awards for brand protection security technology and innovation and is being implemented by a number of leading brand owners and government agencies around the world. For further information, please visit www.ingeniatechnology.com

Marketing Sponsor:

JURA
The Jura Group has become a brand in the high security prepress market in the last 20 years. It is a reputed supplier of proprietary graphical software developed for banknote and security printers and for licensing special patented security features for the protection of banknotes, passports, ID-cards and other security documents.
JURA also supplies customers with ultra-high-resolution input and output devices for security prepress applications. With headquarter in Budapest, Hungary, the sales and customer services are conducted from offices in Vienna and Bangkok. The JURA Group is privately owned and managed by the founder since 1986. For further information, please visit www.jura.at

Junior Sponsor:

RW Pierce
For further information, please visit: www.rwpierce.com

Junior Marketing Sponsor:

Vesdo Ltd.
Established in 2000, Vesdo Ltd. is today a leading security engineering and brand protection company, primarily specialising in building comprehensive security architecture, safeguarding protection in view of diversion, fraud and counterfeiting.
We believe that every company's image and viability are highly associated with its brand. Helping you to authenticate, verify and track & trace your valuables globally against illicit activities of counterfeits is our daily business.
We provide technologies for:
- Product Authentication
- Product Verification
- Track & Trace
For further information, please visit www.vesdo.com

Media Partners:

PharmiWeb.com
PharmiWeb.com is the leading industry-sponsored portal for the pharmaceutical sector. Supported by most of the leading pharmaceutical corporations, PharmiWeb.com provides dynamic real-time news, features, events listings and international jobs to industry professionals across Europe and the US. For further information please email: corporate@pharmiweb.com

BIOTECHNOLOGY EUROPE
BIOTECHNOLOGY EUROPE is owned by BIOTECHNOLOGY WORLD. It is based and located in Warsaw, Poland. Biotechnology World was founded in 2007 to provide the world’s biotech and pharma information and market to make it universally accessible and useful for scientific and business processes. Its first step to fulfilling that mission was building the BIOTECHNOLOGY EUROPE platform that will allow a quick spread of information in different channels. BIOTECHNOLOGY EUROPE offers companies completed internet public relations, publication and marketing solutions. One of the main goals of BIOTECHNOLOGY EUROPE is to integrate the Biotech and Pharma Sector in Europe to global biotechnology, pharmaceutical and life science activities. For further information please visit www.biotechnology-europe.com

Future Pharmaceuticals
Future Pharmaceuticals has forged powerful relationships with key industry leaders to provide a platform for successful brand recognition, and for senior decision-makers to have the means to procure and plan implementation strategies based on the topics covered. Positioned to be an authoritative resource within top pharma companies as well as small, specialty, and biotech, Future Pharmaceuticals magazine is geared to create a deep penetration into a highly targeted and responsive audience, bridging the gap between the industries’ top issues and the solutions top-tier vendors can provide. For further information please visit: www.futurepharmaus.com

InPharm
InPharm is the online platform for exclusive pharmaceutical news, comment, contracts, services, jobs and events and is home to InPharmjobs.com, Pharmafi le and Pharmafocus. For further information please visit: www.In-Pharm.com

Pharmaceutical Manufacturing and Packing Sourcer
Pharmaceutical Manufacturing and Packing Sourcer is a specialist journal providing coverage of topics in the pharmaceutical manufacturing and packaging sectors. It provides a platform of information-sharing for executive decision-makers within the industry, identifying trends and marketing opportunities, and highlighting innovations. For further information please visit: www.samedanltd.com/magazine/15

SecuringPharma.com
SecuringPharma.com is a free-to-access information service that covers the issues surrounding counterfeit medicines and supply chain security in the pharmaceutical industry. Our aim is to provide practical advice and market intelligence to help drugmakers keep up-to-date with developments in the field and define their own strategies to safeguard the supply chain, from raw materials right through to the patient. For further information please visit: www.SecuringPharma.com

Pharma and Healthcare Insight
Pharma and Healthcare Insight provides subscribers with analysis, forecasts and company profi les on a country-by-country basis, covering the key trends impacting on global pharma and healthcare markets. The service includes online access to the very latest analysis and data, a searchable archive, and PDF access to the monthly regional Insight reports. Published by Business Monitor International, the global market specialists, Pharma and Healthcare Insight is broken down into fi ve regional services: Asia, Western Europe, Emerging Europe, the Middle East & Africa and the Americas. For further information please visit: www.pharmaceuticalsinsight.com

BPCouncil
BPCouncil is a dynamic virtual community dedicated to brand protection and intellectual property professionals addressing the wide spectrum of brand protection and intellectual property issues; technology, legal developments, market leaders, news and more. Members have access to a diverse host of resources including networking tools, comprehensive directories, glossary, calendar, market leader profiles, news, blogs, forums, webinars, podcasts and in depth stories. For further information, please visit www.bpcouncil.com

Pharma Connections Worldwide
Pharma Connections Worldwide® is the leading professional business networking website focused in the Pharmaceutical, Biotechnology and Life Sciences research industry. Our goal is to provide a conduit for delivery of premiere content coupled with the right clientele in order to facilitate business development opportunities among industry professionals responsible for making key decisions in a global marketplace. For further information please visit www.pharmaconnections.com

European Association of Chemical Distributors (FECC)
For further information, please visit www.fecc.org

Enquiries

If you would like more information on the range of sponsorship or exhibition possibilities for visiongain's 4th Annual Pharmaceutical Anti-Counterfeiting Strategies Conference, please contact:
Ronald Reyes Magali, +44 (0)20 7549 9934
ronald.magali@visiongainglobal.com
Sandra Clout PhD, +44 (0)20 7549 9969
sandra.clout@visiongainglobal.com

Past Papers

Speaker presentations are free to delegates. If you are unable to attend the event, the presentations are published two weeks after the event and are available to purchase.

Buy Now